AzTrials
AzTrials

Recurrent Laryngeal Nerve PalsyNCT04986592

Predisection Risk Factors for Vocal Cord Palsy After Total Thyroid Surgery

An observational study of Recurrent Laryngeal Nerve Palsy and Risk Factors of Vocal Cord Palsy, run by Hospital Universitari Vall d'Hebron Research Institute.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

In patients undergoing total thyroidectomy, intraoperative nerve monitoring according to the International Standards Guideline Statement may detect nerves more susceptible to injury. Read more about this study

Who is it for?
Ages 18 years and older
How many people
106 participants
Where
No sites listed yet
Study dates
Apr 2014to Dec 2015
How long will I take part?
1 Year
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Study population: All consecutive adult patients undergoing total thyroidectomy during a 12-month period. All patients understood the various aspects of the study and gave written informed consent.

Who may be able to join

  • To be at least 18 years old, to accept participation in the study, and to be scheduled for a total bilateral thyroidectomy.

Who cannot join

  • Urgent thyroidectomy, inability to perform videostroboscopy, minor patients, patient refuse to be part of the study

About this study

Official title: Recurrent Laryngeal Nerve Monitoring for the Assessment of the Vocal Cords in Thyroid Surgery

In patients undergoing total thyroidectomy, intraoperative nerve monitoring according to the International Standards Guideline Statement may detect nerves more susceptible to injury. The aim of our study was to evaluate the independent risk factors of vocal cord palsy, including those related to pre-dissection nerve monitoring values.

Methods: Prospective observational study in 95 consecutive adult patients undergoing elective total thyroidectomy in Spain. A single experienced phonologist performed a videostroboscopy (VS) exam preoperatively and one week after surgery to assess vocal cord mobility. Each surgical procedure was performed with intermittent intraoperative neuromonitoring. Latency and amplitude values were obtained for the vagal and recurrent laryngeal nerves before surgical dissection and compared with the postoperative VS exam.

Read the detailed description

After ethics committee approval (PR AG 129/2014), a prospective observational study was carried out at Vall d'Hebron University Hospital, a tertiary hospital in Barcelona, Spain, in accordance with the Standards for Reporting of Diagnostic Accuracy (STARD), including all consecutive adult patients undergoing total thyroidectomy during a 12-month period. All patients understood the various aspects of the study and gave written informed consent. Patient characteristics recorded were age, sex, body mass index, ASA grade, and reason for surgery, among others.

Intraoperative neuromonitoring: Neural monitoring was performed once the carotid neurovascular bundle had been identified and throughout the surgical dissection process to ensure functional integrity of the nerve. We used Avalanche XT® (Dr Langer Medical GmbH, Waldkirch, Germany) equipment fitted with paired electrodes on the tracheal tube, in contact with the vocal cords (7-10 mm above the upper edge of the tube). Intermittent neuromonitoring was performed in each patient according to the international standard guidelines for electrophysiological monitoring20. The VN and RLN were stimulated following the four-step technique (V1: initial vagal stimulation, prior identification and dissection of the VN, R1: initial stimulation of the RLN, R2: post-dissection RLN stimulation, V2: post-dissection vagal stimulation). Vagal stimulation confirmed proper functioning of the entire neuronal circuit, while also avoiding false negatives through stimulation of an injured distal RLN at the lesion site. All signals were recorded on a monitor and collected for evaluation. Vagal and RLN stimulation was programmed at 3 mA and 1 mA, respectively. The event threshold was set to 70-100 uV, and increased to 200 uV, to avoid false-positive events appearing on the monitor due to spontaneous low-level respiratory waves < 100 uV. Electromyographic signals (latency and amplitude) as well as biphasic and triphasic waves were displayed on the monitoring screen. Lack of signal occurred when the monitor showed low-amplitude waves, disturbance of the isoelectric line, multiple waves of variable and scant amplitude, interference or substantial reduction in electromyography response (< 100 uV), and a high-pitched warning sound.

Vocal cords were assessed using VS (Laryngeal Strobe 9400, Pentax Medical, USA) by a single experienced phonologist blinded to the IONM results. The VS exam was performed preoperatively and repeated one week after surgery. The diagnosis of palsy (absence of motion) was made on the basis of an observation of asymmetrical laryngeal motion. Patients with postoperative VCP began voice therapy and were monitored periodically to assess their progress.

Statistics:

The main aim of the present study was to identify independent risk factors for VCP, including those related with pre-dissection IONM values. Continuous variables are expressed as the mean (standard deviation) or the median and interquartile range (i.q.r.) prior to verification of normality by the Kolmogorov-Smirnov test, and categorical variables are expressed as the absolute value (percentage).

The IONM results (response amplitude in uV and latency in ms) were compared with VS findings and classified as true positives (TP) when IONM values were abnormal and VCP was confirmed by VS, as true negatives (TN) when IONM values were normal and vocal cord mobility was normal on VS, as false positives (FP) when IONM values were obviously abnormal but vocal cord mobility was normal on VS, and as false negatives (FN) when IONM values were normal but VS revealed VCP. These IONM results were used to calculate sensitivity, specificity, positive predictive value (PPV), negative predictive value (NPV), Youden incidence, with the respective 95% confidence interval (CI).

Perioperative variables included sex, age, BMI, ASA grade, neoplasm diagnosis, lymphadenectomy, and surgery. The bivariate relationship between each factor and the VCP results was analysed using an independent sample t test or the Mann-Whitney U-test, as appropriate, for continuous variables, and using the χ2 or Fisher exact test for dichotomous categorical variables. Receiver operating characteristic (ROC) curves were also plotted to determine the best cut-off points for pre-dissection latency and response amplitude for both VN and RLN to predict postoperative palsy.

These cut-off points were then included in the forward stepwise multivariate logistic regression to identify independent risk factors for VCP. Candidate variables for the logistic regression included sex, age, BMI, neoplasm diagnosis, lymphadenectomy, surgery duration, American Society of Anesthesiologists (ASA) classification, and IONM-related predictive factors such as pre-dissection VN latency, pre-dissection VN response amplitude, pre-dissection RLN latency, and pre-dissection RLN response amplitude.

The odds ratio (OR) and 95% CI were also calculated for all exposure factors. In all cases, the level of significance was set at less than 0.05. The statistical analysis was performed using the software package SPSS version 23.0 (IBM, Armonk, New York, USA).

Medical subject headings
Vocal Cord Paralysis

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Response amplitude in recurrent laryngeal nerve in uV

    Response amplitude reflects summated EMG activity from individual muscle fibers of the thyroarytenoid. We define monitoring waveform response amplitude as the height from the vertical measurement from the apex of the positive waveform deflection to the lowest point in the opposite polarity phase of the waveform ( peak to peak). Lack of signal occurred when the monitor showed low-amplitude response waves, in electromyography response (< 100 uV), and a high-pitched warning sound.

    Measured: Adult patients undergoing total thyroidectomy during a 12-month period

  2. Response amplitude in vagal nerve in uV

    Response amplitude reflects summated EMG activity from individual muscle fibers of the thyroarytenoid. We define monitoring waveform response amplitude as the height from the vertical measurement from the apex of the positive waveform deflection to the lowest point in the opposite polarity phase of the waveform ( peak to peak). Lack of signal occurred when the monitor showed low-amplitude response waves, in electromyography response (< 100 uV), and a high-pitched warning sound.

    Measured: Adult patients undergoing total thyroidectomy during a 12-month period

  3. Vocal cord palsy

    Vocal cords were assessed using videostroboscopy(Laryngeal Strobe 9400, Pentax Medical, USA) by a single experienced phonologist blinded to the neuromonitoring results

    Measured: The VS exam was performed one week after surgery, through study completion, an average of 1 yearThe diagnosis of palsy (absence of motion) was made on the basis of an observation of asymmetrical laryngeal motion.

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted3 Aug 2021
  2. Study startApr 2014
  3. Primary completionMay 2015
  4. Study completionDec 2015

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Other
Time perspective
Prospective
Enrolment
106 participants (actual)
Target duration
1 Year
IDs, dates and publications
ClinicalTrials.gov ID
NCT04986592
Sponsor's protocol ID
PR AG 129/2014
Status last verified
Aug 2021
First submitted
16 Jun 2021
Last updated
5 Aug 2021
Results posted
No

Questions about this trial

What is this clinical trial studying?

An observational study of Recurrent Laryngeal Nerve Palsy and Risk Factors of Vocal Cord Palsy, run by Hospital Universitari Vall d'Hebron Research Institute.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 5 Aug 2021. Status can change between updates, so confirm with the study contact before making plans.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Response amplitude in recurrent laryngeal nerve in uV (time frame: Adult patients undergoing total thyroidectomy during a 12-month period). The study lists 3 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 5 Aug 2021.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in